Loading…

Actinidia arguta extract attenuates inflammasome activation: Potential involvement in NLRP3 ubiquitination

Actinidia arguta (A. arguta) has been widely used in Asian countries as a traditional medicinal herb to treat inflammation-related diseases, such as gastritis, bronchitis, and arthritis. The inhibitory effect of A. arguta leaves’ extract (AA) on inflammasome activation was investigated to verify its...

Full description

Saved in:
Bibliographic Details
Published in:Journal of ethnopharmacology 2018-03, Vol.213, p.159-165
Main Authors: Heo, Kang-Hyuck, Sun, Xiao, Shim, Do-Wan, Kim, Myong-Ki, Koppula, Sushruta, Yu, Sang–Hyeun, Kim, Han-Bi, Kim, Tack-Joong, Kang, Tae-Bong, Lee, Kwang-Ho
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Actinidia arguta (A. arguta) has been widely used in Asian countries as a traditional medicinal herb to treat inflammation-related diseases, such as gastritis, bronchitis, and arthritis. The inhibitory effect of A. arguta leaves’ extract (AA) on inflammasome activation was investigated to verify its traditional use in treating inflammation-related diseases. Bone marrow-derived macrophages (BMDMs) primed by lipopolysaccharide (LPS) were activated by selective inflammasome stimulators, and the effect of AA on inflammasome activation was investigated. A monosodium urate crystal (MSU)-induced peritonitis mouse model was used to study the in vivo efficacy of AA on inflammasome activation. In the in vitro study, AA regulated NLRP3 ubiquitination and apoptosis-associated speck-like protein containing a CARD (ASC) oligomerization, leading to the inhibition of NLRP3 inflammasome-mediated interleukin (IL)-1β secretion. The inhibitory effect of AA on inflammasome activation in vitro was further confirmed in vivo using an MSU-induced peritonitis mouse model. AA provided scientific evidence, substantiating the traditional claims for its use in the treatment of inflammation and inflammation-mediated metabolic disorders, including gout. [Display omitted]
ISSN:0378-8741
1872-7573
DOI:10.1016/j.jep.2017.11.023